The Fixed Dose Combination of Sofosbuvir and Velpatasvir is Safe and Effective in Patients of Chronic Hepatitis C With End-stage Renal Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Fixed Dose Combination of Sofosbuvir and Velpatasvir is Safe and Effective in Patients of Chronic Hepatitis C With End-stage Renal Disease

Published:2024-07 Issue:4 Volume:14 Page:101367
ISSN:0973-6883
Container-title:Journal of Clinical and Experimental Hepatology
language:en
Short-container-title:Journal of Clinical and Experimental Hepatology

Author:

Behera Manas K.,Majji Prabir^ORCID,Behera Sanatan,Pani Manoj,Mohapatro Arupam^ORCID,Patra Umesh C.,Jena Susanta K.

Publisher

Elsevier BV

Reference24 articles.

1. Direct-acting antiviral in the treatment of chronic hepatitis C: bonuses and challenges;Zeng;Int J Med Sci,2020

2. Impact of all-oral direct-acting antivirals on clinical and economic outcomes in patients with chronic hepatitis C in the United States;Park;Hepatology,2019

3. Hepatitis C virus and liver transplantation;Bhamidimarri;Gastroenterol Hepatol,2017

4. Tackling the hepatitis C disease burden in Punjab, India;Dhiman;J ClinExpHepatol,2016

5. Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment;Selcuk;Dig Dis Sci,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP